GlassScriptPhysician profile
Jacquelynne B Prince
NPI 1295853158
$8,099.26
in general payments reported to CMS, 2019-2025
10 companies · $572 in 2025
The $572 reported for 2025 was more than what 75% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,154 · 2022: $3,000 · 2023: $253 · 2024: $122 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,975.66 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $460.80 | 2021-2025 | Fasenra, Breztri |
| Medtronic, INC. | $137.47 | 2023 | Hawkone, Venaseal |
| Glaxosmithkline, LLC. | $121.83 | 2024 | Arexvy |
| Abbott Laboratories | $121.18 | 2025 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $108.01 | 2025 | Auvelity |
| Neurocrine Biosciences, INC. | $98.71 | 2025 | |
| Janssen Biotech, INC. | $40.05 | 2021 | |
| Daiichi Sankyo INC. | $22.25 | 2023 | Injectafer |
| Pfizer INC. | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelynne Prince listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.